Gene · 3207
Papers1,952
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,952
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma. | Cancer Discov | 2023 | 36700848 | PubTator, text mining | PubMed |
| Chitosan-based nanoscale systems for doxorubicin delivery: Exploring biomedical application in cancer therapy. | Bioeng Transl Med | 2023 | 36684100 | PubTator, text mining | PubMed |
| Berberine-A Promising Therapeutic Approach to Polycystic Ovary Syndrome in Infertile/Pregnant Women. | Life (Basel) | 2023 | 36676074 | PubTator, text mining | PubMed |
| Changes in Hox Gene Chromatin Organization during Odontogenic Lineage Specification. | Genes (Basel) | 2023 | 36672939 | PubTator, text mining | PubMed |
| The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer. | Biomolecules | 2023 | 36671544 | PubTator, text mining | PubMed |
| lncRNA HOXA11-AS maintains the stemness of oral squamous cell carcinoma stem cells and reduces the radiosensitivity by targeting miR-518a-3p/PDK1. | J Oral Pathol Med | 2023 | 36661031 | PubTator, text mining | PubMed |
| Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesis. | Exp Mol Med | 2023 | 36653445 | PubTator, text mining | PubMed |
| Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia. | Cancer Med | 2023 | 36621846 | PubTator, text mining | PubMed |
| Protocol to analyze bioenergetics in single human induced-pluripotent-stem-cell-derived kidney organoids using Seahorse XF96. | STAR Protoc | 2023 | 36607813 | PubTator, text mining | PubMed |
| Anesthetic‑specific lncRNA and mRNA profile changes in blood during colorectal cancer resection: A prospective, matched‑case pilot study. | Oncol Rep | 2023 | 36562401 | PubTator, text mining | PubMed |
| Reduced-intensity conditioning is effective for allogeneic hematopoietic stem cell transplantation in infants with MECOM-associated syndrome. | Int J Hematol | 2023 | 36515795 | PubTator, text mining | PubMed |
| Non-coding RNA regulation of integrins and their potential as therapeutic targets in cancer. | Cell Oncol (Dordr) | 2023 | 36512308 | PubTator, text mining | PubMed |
| Surgical removal of FIGO type 0 and 1 fibroids ameliorates the expression of endometrial proinflammatory transcription factors and receptivity modulators. | Fertil Steril | 2023 | 36473610 | PubTator, text mining | PubMed |
| nc-RNA-mediated high expression of CDK6 correlates with poor prognosis and immune infiltration in pancreatic cancer. | Cancer Med | 2023 | 36457244 | PubTator, text mining | PubMed |
| Maternal exposure to di(2-ethylhexyl) phthalate (DEHP) causes multigenerational adverse effects on the uterus of F1 and F2 offspring rats. | Reprod Toxicol | 2023 | 36435455 | PubTator, text mining | PubMed |
| HOXA11 is another monogenic cause of congenital anomalies of the kidney and urinary tract-Reply. | Pediatr Nephrol | 2023 | 36401625 | PubTator, text mining | PubMed |
| HOXA11 is another monogenic cause of congenital anomalies of the kidney and urinary tract. | Pediatr Nephrol | 2023 | 36251073 | PubTator, text mining | PubMed |
| Defective binding of ETS1 and STAT4 due to a mutation in the promoter region of THPO as a novel mechanism of congenital amegakaryocytic thrombocytopenia. | Haematologica | 2023 | 36226497 | PubTator, text mining | PubMed |
| The name counts: the case of 'congenital amegakaryocytic thrombocytopenia'. | Haematologica | 2023 | 36226496 | PubTator, text mining | PubMed |
| Using period analysis to timely assess and predict 5-year relative survival for colorectal cancer patients in Taizhou, eastern China. | Cancer Med | 2023 | 36065512 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3207/papers?page=13